Clinical Trials Logo

Clinical Trial Summary

Premature ovarian failure (POF) is a rare condition, affecting 1 in 10,000 women before age 20 and 1 in 1,000 women before age 30. The two main causes of POF are congenital and acquired. Patients with POF who carry out the desire to have a child turn to medically assisted reproduction through oocyte donation or to adoption. The main endpoint of this study is to compare the desire to have children among women with premature ovarian failure (POF) aged 18 to 26 years vs. controls of the same age (stratified by age) without major menstruation disorder.


Clinical Trial Description

Premature ovarian failure (POF) is a rare condition, affecting 1 in 10,000 women before age 20 and 1 in 1,000 women before age 30. The two main causes of POF are congenital and acquired. Patients with POF who carry out the desire to have a child turn to medically assisted reproduction through oocyte donation or to adoption. The main endpoint of this study is to compare the desire to have children among women with premature ovarian failure (POF) aged 18 to 26 years vs. controls of the same age (stratified by age) without major menstruation disorder. The primary endpoint is the percentage of women with POF reporting a desire to have a child (yes / no) vs. controls of the same age with normal gonadal function/ The answers will be collected on two online questionnaires. The secondary endpoints are: - Look for a difference in the desire for a child according to the age at the diagnosis of POF, the cause of POF, the intake of hormone replacement therapy and the age of the patients at the time of the study. - Assess the sexual life of women in POF. - Assess the psychological state of women with POF-related infertility and help identify those with symptoms of anxiety or depression. He will be assessed by the Hospital Anxiety and Depression Questionnaire to help identify those with symptoms of anxiety or depression. The women will be contacted by email and will receive a newsletter. The controls will be recruited from patients who have visited at least once at bicetre Hospital and who do not have a condition that could impair fertility. They must not have been pregnant or must not be pregnant at the time of the study. The email will contain a questionnaire. We estimate that 120 patients will meet the inclusion and non-inclusion criteria among the patients on the Unit. Considering that 80 patients (2/3) will answer the questionnaires, we will be able to include 80 patients and 80 controls in our study. The proportion of women wishing to have children, in the general population, in the study age group is estimated at 90%. Including 160 participants will allow us to show a 20% difference in the proportion of desire to have children in patients with POF, with a power of 90%, an alpha risk of 5% and a bilateral formulation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04881695
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Lise DURANTEAU, Doctor
Phone 00331 45 21 78 41
Email lise.duranteau@aphp.fr
Status Not yet recruiting
Phase
Start date May 10, 2021
Completion date January 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03535480 - Autologous Bone Marrow Stem Cell Ovarian Transplantation to Restore Ovarian Function in Premature Ovarian Failure Phase 4
Recruiting NCT02086318 - A New Algorithm to Predict Ovarian Age N/A
Recruiting NCT01411644 - Pheno- & Genotyping POF (WHO III)